Effective monitoring of patients should include a thorough history and physical examination, including neurologic function and bowel habits, a complete dermatologic assessment, and baseline as well as serial monitoring of LFTs, endocrine panel, and TFTs; plus ACTH. CrCl, and blood chemistry, both at baseline and before each dose. Additional monitoring includes a pregnancy test at baseline for female patients of child-bearing age.